50-254-4124

PD-L1 (Atezolizumab) Recombinant Human Monoclonal Antibody (Atezolizumab), Functional Grade, Leinco Technologies™

Manufacturer: Leinco Technologies Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-254-4124-Each-of-1 In Stock ₹ 4,89,317.64

50-254-4124 - Each of 1

₹ 4,89,317.64

In Stock

Quantity

1

Base Price: ₹ 4,89,317.64

GST (18%): ₹ 88,077.175

Total Price: ₹ 5,77,394.815

Antigen

PD-L1 (Atezolizumab)

Classification

Recombinant Monoclonal

Concentration

≥5.0 mg/mL

Formulation

PBS with no preservative; pH 7.2-7.4

Host Species

Human

Purification Method

Protein A/G

Regulatory Status

RUO

Target Species

Human

Product Type

Antibody

Isotype

IgG

Applications

Flow Cytometry, Western Blot

Clone

Atezolizumab

Conjugate

Functional Grade

Gene Alias

MPDL3280A; RG7446; Tecentriq

Immunogen

Recombinant extracellular domain-Fc fusion of human PD-L1R

Quantity

100 mg

Primary or Secondary

Primary

Content And Storage

4°C short term, -80°C long term

Form

Liquid

Related Products

Img

Leinco Technologies Inc

50-254-4120

--

Img

Leinco Technologies Inc

50-254-4117

--

Img

Leinco Technologies Inc

50-254-4133

--

Img

Leinco Technologies Inc

50-254-4118

--

Img

Leinco Technologies Inc

50-254-4126

--

Img

Leinco Technologies Inc

50-254-4130

--

Img

Leinco Technologies Inc

50-254-4122

--

Img

Leinco Technologies Inc

50-254-4132

--

Description

  • Specificity: Atezolizumab (RG7446; INN or code name MPDL3280A) activity is directed against PD-L1 (CD274) and B7.1 (CD80)
  • Endotoxin Level: <1.0 EU/mg as determined by the LAL method
  • Purity: ≥95% monomer by analytical SEC
  • Preparation: Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates
  • Storage: Functional grade biosimilar antibodies may be stored sterile as received at 2-8C for up to one month
  • For longer term storage, aseptically aliquot in working volumes without diluting and store at -80C
  • Avoid Repeated Freeze Thaw Cycles
  • PD-L1 (Atezolizumab) Recombinant Monoclonal antibody specifically detects PD-L1 (Atezolizumab) in Human samples
  • It is validated for Flow Cytometry, Western Blot

Compare Similar Items

Show Difference

Img

Leinco Technologies Inc

50-254-4124

--


Antigen:
PD-L1 (Atezolizumab)

Classification:
Recombinant Monoclonal

Concentration:
≥5.0 mg/mL

Formulation:
PBS with no preservative; pH 7.2-7.4

Host Species:
Human

Purification Method:
Protein A/G

Regulatory Status:
RUO

Target Species:
Human

Product Type:
Antibody

Isotype:
IgG

Applications:
Flow Cytometry, Western Blot

Clone:
Atezolizumab

Conjugate:
Functional Grade

Gene Alias:
MPDL3280A; RG7446; Tecentriq

Immunogen:
Recombinant extracellular domain-Fc fusion of human PD-L1R

Quantity:
100 mg

Primary or Secondary:
Primary

Content And Storage:
4°C short term, -80°C long term

Form:
Liquid

Img

Leinco Technologies Inc

50-254-4126

--


Antigen:
CTLA-4 (Ipilimumab)

Classification:
Recombinant Monoclonal

Concentration:
≥5.0 mg/mL

Formulation:
PBS with no preservative; pH 7.2-7.4

Host Species:
Human

Purification Method:
Protein A/G

Regulatory Status:
RUO

Target Species:
Human

Product Type:
Antibody

Isotype:
IgG1 κ

Applications:
ELISA, Flow Cytometry, Inhibition Assays, Mass Spectrometry

Clone:
MDX-010

Conjugate:
Functional Grade

Gene Alias:
BMS-734016; MDX-010; MDX-CTLA-4; Yervoy

Immunogen:
Human CTLA-4

Quantity:
500 μg

Primary or Secondary:
Primary

Content And Storage:
4°C short term, -80°C long term

Form:
Liquid

Img

Bioworld

50-254-413

--


Antigen:
__

Classification:
__

Concentration:
__

Formulation:
__

Host Species:
__

Purification Method:
__

Regulatory Status:
__

Target Species:
__

Product Type:
__

Isotype:
__

Applications:
__

Clone:
__

Conjugate:
__

Gene Alias:
__

Immunogen:
__

Quantity:
__

Primary or Secondary:
__

Content And Storage:
__

Form:
__

Img

Leinco Technologies Inc

50-254-4130

--


Antigen:
CD279 (PD-1) (Nivolumab)

Classification:
Recombinant Monoclonal

Concentration:
≥5.0 mg/mL

Formulation:
PBS with no preservative; pH 7.2-7.4

Host Species:
Human

Purification Method:
Protein A/G

Regulatory Status:
RUO

Target Species:
Cynomolgus Monkey, Human

Product Type:
Antibody

Isotype:
IgG1 κ

Applications:
Flow Cytometry, Functional Assay, Immunohistochemistry, Inhibition Assays

Clone:
5C4.B8

Conjugate:
Functional Grade

Gene Alias:
BMS-936558; MDX-1106; ONO-4538; Opdivo

Immunogen:
Human PD-1

Quantity:
500 μg

Primary or Secondary:
Primary

Content And Storage:
4°C short term, -80°C long term

Form:
Liquid